BiotechTube
Home/TendoNova/Mark A. Samuels
MA

Mark A. Samuels

Chief Executive Officer

TendoNova

Therapeutic Areas

OrthopedicsSports MedicineMusculoskeletal Disorders

TendoNova Pipeline

DrugIndicationPhase
Percutaneous Tenotomy DeviceChronic Tendinopathies (e.g., Tennis Elbow, Plantar Fasciitis, Rotator Cuff)Commercial

Leadership Team at TendoNova

JS
Jonathan Shaw
Co-Founder & Director
KM
Kenneth Mautner, MD
Medical Advisor
RA
Robert A. Toni
National Sales Director
View full TendoNova profile